Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Krahn

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 29, 2014
Prostate cancer screening: going beyond the clinical evidenceMurray Krahn
JAMA|July 24, 2008
The next step in guideline development: incorporating patient preferencesMurray Krahn, Gary Naglie
Pharmacoeconomics|April 21, 2011
Health economic and infectious disease modelling: a guide to merging streamsAndrea Anonychuk, Murray Krahn
ACP Journal Club|September 2, 2006
Review: ribavirin is not better than placebo in chronic hepatitis C infectionWendong Chen, Murray Krahn
Canadian Respiratory Journal|October 8, 2003
Economic issues in the use of office spirometry for lung health assessmentMurray Krahn, Kenneth R Chapman
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 3, 2012
The future of health technology assessmentAhmed M Bayoumi, Murray Krahn
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 5, 2014
Screening for HCVWilliam W L Wong, Murray Krahn
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
A recommender system for prostate cancer websitesHolly Witteman, Mark Chignell, Murray Krahn
Arthritis and Rheumatism|June 10, 2003
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritisAndreas Maetzel, Murray Krahn, Gary Naglie
BMC Medical Research Methodology|September 7, 2013
Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortalityNicholas Mitsakakis, Harindra C Wijeysundera, Murray Krahn
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 29, 2014
Prostate cancer screening: going beyond the clinical evidenceMurray Krahn
JAMA|July 24, 2008
The next step in guideline development: incorporating patient preferencesMurray Krahn, Gary Naglie
Pharmacoeconomics|April 21, 2011
Health economic and infectious disease modelling: a guide to merging streamsAndrea Anonychuk, Murray Krahn
ACP Journal Club|September 2, 2006
Review: ribavirin is not better than placebo in chronic hepatitis C infectionWendong Chen, Murray Krahn
Canadian Respiratory Journal|October 8, 2003
Economic issues in the use of office spirometry for lung health assessmentMurray Krahn, Kenneth R Chapman
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 3, 2012
The future of health technology assessmentAhmed M Bayoumi, Murray Krahn
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 5, 2014
Screening for HCVWilliam W L Wong, Murray Krahn
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
A recommender system for prostate cancer websitesHolly Witteman, Mark Chignell, Murray Krahn
Arthritis and Rheumatism|June 10, 2003
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritisAndreas Maetzel, Murray Krahn, Gary Naglie
BMC Medical Research Methodology|September 7, 2013
Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortalityNicholas Mitsakakis, Harindra C Wijeysundera, Murray Krahn
Pageof 21